Valneva SE (VALN) Profit After Tax (2021 - 2026)
Valneva SE's (VALN) quarterly Profit After Tax came in at -$37.5 million in Q1 2026, down 286.67% year-on-year from $20.1 million in Q1 2025, and up 35.48% quarter-over-quarter from -$58.2 million in Q4 2025.
Valneva SE (VALN) Profit After Tax (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Profit After Tax across 6 years of filings, most recently posting -$37.5 million for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$37.5 million, down 286.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.5 million (up 56.43% YoY), and the FY2025 annual result was -$134.1 million, down 928.53% from the prior year.
- Profit After Tax came in at -$37.5 million for Q1 2026 at Valneva SE, up from -$58.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $38.1 billion in Q2 2023 to a low of -$38.1 billion in Q3 2023.
- The 5-year median for Profit After Tax is -$26.9 million (2024), against an average of -$26.2 million.
- Peak annual rise in Profit After Tax reached 18195.98% in 2023, while the deepest fall reached 14056.89% in 2023.
- Valneva SE's Profit After Tax stood at -$247.3 million in 2022, then increased by 25.72% to -$183.7 million in 2023, then jumped by 78.53% to -$39.4 million in 2024, then plunged by 47.6% to -$58.2 million in 2025, then soared by 35.48% to -$37.5 million in 2026.
- The last three Profit After Tax figures came in at -$37.5 million (Q1 2026), -$58.2 million (Q4 2025), and -$51.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -37.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.55 Mn |
| Dec 31, 2025 | -58.20 Mn |
| Sep 30, 2025 | -51.89 Mn |
| Jun 30, 2025 | -23.57 Mn |
| Mar 31, 2025 | -9.71 Mn |
| Dec 31, 2024 | -39.43 Mn |
| Sep 30, 2024 | -10.19 Mn |
| Jun 30, 2024 | -26.85 Mn |
| Mar 31, 2024 | 64.00 Mn |
| Dec 31, 2023 | -183.66 Mn |
| Sep 30, 2023 | -38.08 Bn |
| Jun 30, 2023 | 38.14 Bn |
| Mar 31, 2023 | 19.46 Mn |
| Dec 31, 2022 | -247.26 Mn |
| Sep 30, 2022 | 272.81 Mn |
| Jun 30, 2022 | -210.78 Mn |
| Mar 31, 2022 | 29.23 Mn |
| Dec 31, 2021 | -365.34 Mn |
| Sep 30, 2021 | 391.91 Mn |
| Jun 30, 2021 | -137.41 Mn |